Eye Therapies, LLC

Patent Applications and Registrations

Patent applications and USPTO patent grants for Eye Therapies, LLC.The latest application filed is for "low-dose brimonidine combinations and uses thereof".

Company Profile

7.9.27

Eye Therapies, LLC - Dana Point CA US
Eye Therapies LLC; - Dana Point CA US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Low-dose Brimonidine Combinations And Uses Thereof App 20220233524 - Horn; Gerald	2022-07-28
Vasoconstriction Compositions And Methods Of Use App 20220142917 - HORN; Gerald	2022-05-12
Anti-viral Compositions And Methods Of Use Thereof App 20220031739 - Horn; Gerald	2022-02-03
Vasoconstriction Compositions And Methods Of Use App 20220000769 - HORN; Gerald	2022-01-06
Low-dose Brimonidine Combinations And Uses Thereof App 20210369706 - Horn; Gerald	2021-12-02
Brimonidine Combinations And Uses Thereof App 20210338666 - Horn; Gerald	2021-11-04
Methods For Improving Vision App 20210259962 - Horn; Gerald	2021-08-26
Methods for improving vision Grant 11,026,884 - Horn June 8, 2	2021-06-08
Netarsudil And Low-dose Brimonidine Combination And Uses Thereof App 20200197398 - Horn; Gerald	2020-06-25
Low-dose Brimonidine Combinations And Uses Thereof App 20200108064 - Horn; Gerald	2020-04-09
Low-dose Brimonidine Combinations And Uses Thereof App 20190374537 - Horn; Gerald	2019-12-12
Vasoconstriction Compositions And Methods Of Use App 20190269681 - Horn; Gerald	2019-09-05
Vasoconstriction Compositions And Methods Of Use App 20190240151 - HORN; Gerald	2019-08-08
Methods For Improving Vision App 20190224115 - Horn; Gerald	2019-07-25
Preferential Vasoconstriction Compositions and Methods of Use App 20180369240 - Horn; Gerald	2018-12-27
Vasoconstriction Compositions And Methods Of Use App 20180360825 - Horn; Gerald	2018-12-20
Low-dose Brimonidine Combinations And Uses Thereof App 20180353504 - Horn; Gerald	2018-12-13
Compositions and methods for eye whitening Grant 9,259,425 - Horn February 16, 2	2016-02-16
Compositions and Methods for the Treatment of Nasal Conditions App 20150119401 - Horn; Gerald	2015-04-30
Formulations of selective alpha-2 agonists and methods of use thereof Grant 8,987,270 - Horn March 24, 2	2015-03-24
Compositions and methods for the treatment of nasal conditions Grant 8,952,011 - Horn February 10, 2	2015-02-10
Compositions and methods for eye whitening Grant 8,765,758 - Horn July 1, 2	2014-07-01
Compositions and Methods for Eye Whitening App 20140038973 - Horn; Gerald	2014-02-06
Compositions and Methods for Eye Whitening App 20140038974 - Horn; Gerald	2014-02-06
Compositions and Methods for the Treatment of Nasal Conditions App 20130345229 - Horn; Gerald	2013-12-26
Compositions and methods for reducing activation of alpha-1 receptors Grant 8,580,787 - Horn November 12, 2	2013-11-12
Compositions and Methods for Treatment of Glaucoma App 20130172357 - Horn; Gerald	2013-07-04
Compositions and Methods for the Treatment of Migraine App 20130143938 - Horn; Gerald	2013-06-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.